Effectiveness of Black Peel with 1% Clotrimazole Cream vs Oral Terbinafine in the Treatment of Onychomycosis-Randomized Controlled Trial
DOI:
https://doi.org/10.70749/ijbr.v3i6.2193Keywords:
Onychomycosis, Terbinafine, 1% clotrimazole, Black peel.Abstract
Background: Onychomycosis accounts for 90% of all the toe nail infections and 30 % of all cutaneous fungal infections.(1) The management of this disease is challenging, as on one end there is increasing evidence of growing fungal resistance against available antifungals; and on the other end the majority of the effected individuals are old aged and have comorbidities limiting the use of systemic treatment in such cases.(2) In such circumstances there is an increasing need for exploring newer treatment options for onychomycosis. The aim of the study was to compare the effectiveness of topical back peel combined with 1% clotrimazole versus oral terbinafine in cases of onychomycosis. We hypothesized that this topical combination strategy is better than oral terbinafine in this disease. We carried out a randomized clinical trial in the Dermatology OPD of our tertiary care hospital in Pakistan over a period of 06 months i.e., from March to August 2024. Methods: 90 patients suffering from onychomycosis meeting our inclusion criteria were included in the study after informed consent. Later on, six patients were dropped due to non-compliance issues. Sampling was done by non-probability randomized sampling. Group A was treated by weekly black peel combined with daily 1% clotrimazole cream for 3 months and group B was treated by oral terbinafine 250mg for 03 months. After 03 months of treatment, results were analyzed by observing the change in mean onychomycosis severity index (OSI) and patient satisfaction scores. Results: There was lesser OSI in group B (1.43±2.25) as compared to group A (5.32±6.5) after treatment with significant p value of o.oo3. The mean difference between the groups was 3.887±1.08. But within each group there was a significant difference in pre-treatment to post treatment OSI (p=<0.001 in each group). Conclusion: Black peeling combination with topical 1% clotrimazole is a comparable treatment option to oral terbinafine for the treatment of onychomycosis.
Downloads
References
1. Gupta AK, Elewski B, Joseph WS, Lipner SR, Daniel CR, Tosti A, et al. Treatment of onychomycosis in an era of antifungal resistance: Role for antifungal stewardship and topical antifungal agents. Vol. 67, Mycoses. 2024.
https://doi.org/10.1111/myc.13683
2. Gupta AK, Versteeg SG, Shear NH. Onychomycosis in the 21st century: An update on diagnosis, epidemiology, and treatment. Vol. 21, Journal of Cutaneous Medicine and Surgery. 2017.
https://doi.org/10.1177/1203475417716362
3. Leung AKC. Onychomycosis: An Updated Review. Recent Pat Inflamm Allergy Drug Discov. 2022;14(1).
https://doi.org/10.2174/22122710mtaxwoter2
4. Velasquez-Agudelo V, Cardona-Arias JA. Meta-analysis of the utility of culture, biopsy, and direct KOH examination for the diagnosis of onychomycosis. BMC Infect Dis. 2017;17(1).
https://doi.org/10.1186/s12879-017-2258-3
5. Nenoff P, Reinel D, Mayser P, Abeck D, Bezold G, Bosshard PP, et al. S1 Guideline onychomycosis. JDDG - Journal of the German Society of Dermatology. 2023;21(6).
https://doi.org/10.1111/ddg.14988
6. Falotico JM, Lipner SR. Updated Perspectives on the Diagnosis and Management of Onychomycosis. Vol. 15, Clinical, Cosmetic and Investigational Dermatology. 2022.
https://doi.org/10.2147/ccid.s362635
7. Lim SS, Ohn J, Mun JH. Diagnosis of Onychomycosis: From Conventional Techniques and Dermoscopy to Artificial Intelligence. Vol. 8, Frontiers in Medicine. 2021.
https://doi.org/10.3389/fmed.2021.637216
8. Piraccini BM, Alessandrini A. Onychomycosis: A review. Vol. 1, Journal of Fungi. 2015.
https://doi.org/10.3390/jof1010030
9. Maskan Bermudez N, Rodríguez-Tamez G, Perez S, Tosti A. Onychomycosis: Old and New. Vol. 9, Journal of Fungi. 2023.
https://doi.org/10.3390/jof9050559
10. Lecha M, Effendy I, De Chauvin MF, Di Chiacchio N, Baran R. Treatment options - Development of consensus guidelines. Vol. 19, Journal of the European Academy of Dermatology and Venereology. 2005.
https://doi.org/10.1111/j.1468-3083.2005.01284.x
11. Zaki AM, Abdo HM, Ebadah MA, Ibrahim SM. Fractional CO2 laser plus topical antifungal versus fractional CO2 laser versus topical antifungal in the treatment of onychomycosis. Dermatol Ther. 2020;33(1).
https://doi.org/10.1111/dth.13155
12. Kawai M. Characteristics and efficacy of two topical therapeutic agents for onychomycosis: Efinaconazole 10%solution and luliconazole 5% solution. Vol. 60, Medical Mycology Journal. 2019.
https://doi.org/10.3314/mmj.19.006
13. Vlahovic TC, Gupta AK. Efinaconazole topical solution (10%) for the treatment of onychomycosis in adult and pediatric patients. Expert Rev Anti Infect Ther. 2022;20(1).
https://doi.org/10.1080/14787210.2021.1939011
14. El-Tatawy RA, Aliweh HA, Hegab DS, Talaat RAZ, Shams Eldeen MA. Fractional carbon dioxide laser and topical tioconazole in the treatment of fingernail onychomycosis. Lasers Med Sci. 2019;34(9).
https://doi.org/10.1007/s10103-019-02789-2
15. Abd El-Aal EB, Abdo HM, Ibrahim SM, Eldestawy MT. Fractional carbon dioxide laser assisted delivery of topical tazarotene versus topical tioconazole in the treatment of onychomycosis. Journal of Dermatological Treatment. 2019;30(3).
https://doi.org/10.1080/09546634.2018.1509046
16. Bristow IR. The effectiveness of lasers in the treatment of onychomycosis: A systematic review. Vol. 7, Journal of Foot and Ankle Research. 2014.
https://doi.org/10.1186/1757-1146-7-34
17. Lam W, Tosti A. Review on Chemical Peels for Nail Surface Rejuvenation. Skin Appendage Disord. 2023;9(4).
https://doi.org/10.1159/000530629
18. Sonthalia S, Jakhar D, Yadav P, Kaur I. Chemical Peeling as an Innovative Treatment Alternative to Oral Antifungals for Onychomycosis in Special Circumstances. Skin Appendage Disord. 2019;5(3).
https://doi.org/10.1159/000495152
19. Axler E, Lipner SR. Antifungal Selection for the Treatment of Onychomycosis: Patient Considerations and Outcomes. Vol. 17, Infection and Drug Resistance. 2024.
https://doi.org/10.2147/idr.s431526
20. V. Chau T, Mai LP, Nguyen HT, Nay SM, Nguyen HTN, Nguyen TT. Fractional Carbon-Dioxide Laser Plus Topical Clotrimazole versus Oral Itraconazole plus Topical Clotrimazole for Onychomycosis: A Randomized, Controlled Trial. Open Dermatol J. 2020;14(1).
https://doi.org/10.2174/1874372202014010016
21. Gupta AK, Taborda VBA, Taborda PRO, Shemer A, Summerbell RC, Nakrieko KA. High prevalence of mixed infections in global onychomycosis. PLoS One. 2020;15(9 September).
https://doi.org/10.1371/journal.pone.0239648
22. Navarro-Pérez D, García-Oreja S, Tardáguila-García A, León-Herce D, Álvaro-Afonso FJ, Lázaro-Martínez JL. Inter-observer reliability of the Onychomycosis Severity Index depending on clinical experience: A review of 50 cases. Mycoses. 2024;67(1).
https://doi.org/10.1111/myc.13694
23. Kumar R, Sachan P, Singh SK, Gupta AK, Mohan L. A prospective observational study on efficacy of black acetic acid combination peel in patients of facial nodulocystic acne. International Journal of Research in Dermatology. 2019;5(4).
https://doi.org/10.18203/issn.2455-4529.intjresdermatol20194544
24. Karia U, Parghi M, Padhiar B, Shah B. A study of efficacy and safety of newer chemical peels for acne vulgaris grade 1 to grade 3. IP Indian Journal of Clinical and Experimental Dermatology. 2022;8(3).
https://doi.org/10.18231/j.ijced.2022.037
25. León J, Rojo E, Sánchez-Serrano JJ. Wound signalling in plants. Vol. 52, Journal of Experimental Botany. 2001.
https://doi.org/10.1093/jexbot/52.354.1
26. Droby S, Porat R, Cohen L, Weiss B, Shapiro B, Philosoph-Hadas S, et al. Suppressing green mold decay in grapefruit with postharvest jasmonate application. Journal of the American Society for Horticultural Science. 1999;124(2).
https://doi.org/10.21273/jashs.124.2.184
27. A. J. Natural Fungicides Obtained from Plants. In: Fungicides for Plant and Animal Diseases. 2012.
28. Jarocka-Karpowicz I, Markowska A. Jasmonate compounds and their derivatives in the regulation of the neoplastic processes. Vol. 26, Molecules. 2021.
https://doi.org/10.3390/molecules26102901
29. Gupta AK, Nicol K. The use of sulfur in dermatology. Vol. 3, Journal of drugs in dermatology : JDD. 2004.
30. Anzengruber F, Mergenthaler C, Murer C, Dummer R. Potassium Iodide for Cutaneous Inflammatory Disorders: A Monocentric, Retrospective Study. Dermatology. 2019;235(2).
https://doi.org/10.1159/000494614
31. Estrada-Castañón R, Chávez-López G, Estrada-Chávez G, Bonifaz A. Report of 73 cases of cutaneous sporotrichosis in Mexico. An Bras Dermatol. 2018;93(6).
https://doi.org/10.1590/abd1806-4841.20187726
32. Costa RO, Macedo PM de, Carvalhal A, Bernardes-Engemann AR. Use of potassium iodide in Dermatology: updates on an old drug. An Bras Dermatol. 2013;88(3).
https://doi.org/10.1590/abd1806-4841.20132377
33. Espírito Santo RB Do, Deps PD. Case Study of Onychomycosis Patients Treated with 1,064-nm Nd:YAG Laser. Case Rep Dermatol. 2018;10(2).
https://doi.org/10.1159/000492526
34. Nasif GA, Amin AA, Ragaie MH. Q-switched Nd:YAG laser versus itraconazole pulse therapy in treatment of onychomycosis: A clinical dermoscopic and mycologic study. J Cosmet Dermatol. 2023;22(6).
https://doi.org/10.1111/jocd.15660
35. Alberdi E, Gómez C. Urea versus fractional Er:YAG laser pretreatment of methylene blue photodynamic therapy in the treatment of moderate toenail onychomycosis: short- and medium-term effects. Arch Dermatol Res. 2023;315(4).
https://doi.org/10.1007/s00403-022-02448-7
36. Auvinen T, Tiihonen R, Soini M, Wangel M, Sipponen A, Jokinen JJ. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: A prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial. British Journal of Dermatology. 2015;173(4).
https://doi.org/10.1111/bjd.13934
37. Shafi A, Hafeez L, Aslam A, Rashid M, Tahir R, Tanveer A. Comparison of efficacy of continuous terbinafine versus intermittent itraconazole in the treatment of toenail onychomycosis. Journal of Pakistan Association of Dermatologists. 2021;31(3).
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
